CorVel Corporation — Form 10-Q Summary
Period: Three months ended June 30, 2019, CorVel’s first fiscal quarter of 2020. The request metadata says “2018 Q1,” but the filing itself reports the quarter ended June 30, 2019, with comparison to June 30, 2018.
Business context and financial results
CorVel provides managed care and medical cost-containment services, primarily for workers’ compensation, automobile insurance, and group health claims. It reports one operating segment: managed care.
| Metric | Q1 FY2020 | Prior-year quarter |
|---|---|---|
| Revenue | $150.1 million | $150.4 million |
| Gross profit / margin | $33.1 million / 22.1% | $31.4 million / 20.8% |
| Income before tax | $17.4 million | $15.4 million |
| Net income | $13.4 million | $11.8 million |
| Diluted EPS | $0.71 | $0.62 |
| Operating cash flow | $26.4 million | $22.8 million |
| Capital expenditures | $8.0 million | $3.0 million |
Cash and cash equivalents were $104.4 million at June 30, 2019. Working capital was $90.9 million, down from $98.6 million at March 31, 2019. The company had no outstanding borrowings; its revolving credit facility provides up to $10 million and expires in September 2019. Adoption of lease accounting added a $96.7 million right-of-use asset and $99.7 million in operating lease liabilities. These lease obligations are distinct from debt.
Material changes versus the prior comparable period
- Revenue was nearly flat, down 0.2%. Patient management revenue rose 13.2% to $99.5 million, while network solutions revenue fell 19.0% to $50.6 million. Management attributed the network decline in part to a 38.9% reduction in pharmacy-service bills reviewed.
- Gross profit increased 5.7%; management cited operating efficiencies, economies of scale in TPA services, and revenue growth in higher-margin enhanced bill review programs.
- Net income increased 13.8% and diluted EPS increased 14.5%, aided by higher net income and lower diluted weighted-average shares.
- Operating cash flow rose by $3.6 million, primarily due to increased net income and improved collections; days sales outstanding improved from 43 to 41 days.
- Share repurchases totaled $9.1 million, versus $3.5 million in the prior-year quarter. Capital spending increased, mainly due to construction on a building purchased in the greater Portland area.
Outlook, risks, and unusual items
- No specific revenue or earnings guidance was provided. Management said cash, expected internally generated funds, and credit availability should cover expected requirements for at least the next 12 months, including operations, investments, and planned repurchases.
- The $10 million credit facility expires in September 2019; the filing does not state whether it was renewed after quarter-end.
- Management highlighted risks including declining workers’ compensation claim volumes, customer insourcing, competition and pricing pressure, labor and benefit costs, regulatory or legislative changes, cybersecurity and data-system disruptions, and litigation or liability exposure.
- Ordinary-course litigation is ongoing; management does not expect its resolution to have a material financial impact. The company reported no debt outstanding and compliance with credit-facility covenants.
- The company adopted ASC 842 lease accounting on April 1, 2019, with no retained-earnings impact. It reported $6.5 million of additional operating lease commitments for leases not yet commenced.
- Management is still evaluating the impact of the expected-credit-loss standard; it plans to evaluate the effect of the updated goodwill impairment guidance.
Important facts for investors to verify
- Confirm the intended reporting period: the filing covers Q1 FY2020, not a 2018 quarter.
- Track whether patient management growth can offset continued weakness in network solutions, particularly pharmacy-related activity.
- Check renewal or replacement of the revolving credit facility before its September 2019 expiration.
- Review subsequent share repurchases: the filing reports 76,805 additional shares bought after quarter-end for $6.9 million.
- Assess lease commitments and the effect of lease obligations on future cash requirements.
- Monitor the filing’s identified exposure to claim-volume trends, cybersecurity incidents, regulatory changes, and competition.